12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Choline C 11 Injection regulatory update

FDA approved the production and use of IV Choline C 11 Injection at the Mayo Clinic to help detect recurrent prostate cancer. The PET imaging agent is used to help locate...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >